Study Evaluating the Tolerability of Bifeprunox in Healthy Subjects

Wyeth

Status and phase: Completed; Phase 1

Conditions: Healthy

Treatments: Drug: bifeprunox

Study type: Interventional

Funder types: Industry

Identifiers

NCT00581451

3168A2-1005

Details and patient eligibility

About

Safety and tolerability study in healthy volunteers

Enrollment: 144 estimated patients

Sex: All

Ages: 18 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria:

• Healthy male 18-50 years
• Nonlactating female 18-50 years

Trial design

144 participants in 4 patient groups

A

Experimental group

Description:

bifeprunox 25 day

Treatment:

Drug: bifeprunox

B

Experimental group

Description:

bifeprunox 14 day

Treatment:

Drug: bifeprunox

C

Experimental group

Description:

bifeprunox 14 day

Treatment:

Drug: bifeprunox

D

Experimental group

Description:

bifeprunox 9 day

Treatment:

Drug: bifeprunox